Open original FDA record ↗Recall record
- FDA identifier
- Z-1697-2012
- Company in FDA record
- Covidien LLC
- FDA classification date
- May 31, 2012
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 17, 2026
- Recall classification
- Unknown — no matched enforcement classification
Reason stated in the source
Safety shield may separate from the syringe, exposing the needle, which could potentially result in a needle stick
Source facts
- Action
- Covidien sent an Urgent Product Recall letter dated May 21, 2012, via Federal Express. The letter identified the product, the problem, and the action to be taken by the customer. Customers were instructed to immediately stop using any affected product. Distributors were requested to notify their customers. Customers were instructed to complete the Monoject Insulin Safety Syringe recalled product return form even if they have no product to return. The form should be faxed to 1-800-895-6140 or e-mailed to sdfeedback@covidien.com. Customer Service questions regarding the recall please use one of the following methods. Telephone:1-800-722-8772 option I (Weekdays, 8am to 6:30pm Eastern) e-mail:sdfeedback@covidien.com
- Initiated
- 2012-05-21
- Root cause
- Equipment maintenance
- Terminated
- 2013-06-10
- Distribution
- Worldwide Distribution - USA (nationwide) and the countries of Canada, Australia, Belgium, and Panama.
- Recall number
- Z-1697-2012
- Recall status
- Terminated
- CDRH record ID
- 109371
- FDA classified
- 2012-05-31
- Recall event number
- 61908